Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ$_{42}$ to Aβ$_{40}$ ratio by Kuperstein, Inna et al.
Neurotoxicity of Alzheimer’s disease Ab peptides is
induced by small changes in the Ab42 to Ab40 ratio
Inna Kuperstein1,2,10,12, Kerensa
Broersen3,4,10, Iryna Benilova1,2,5,10,
Jef Rozenski6, Wim Jonckheere3,4,
Maja Debulpaep3,4, Annelies
Vandersteen3,4, Ine Segers-Nolten7,
Kees Van Der Werf7, Vinod Subramaniam7,
Dries Braeken5, Geert Callewaert5,
Carmen Bartic5,8, Rudi D’Hooge9,
Ivo Cristiano Martins3,4,11, Frederic
Rousseau3,4,*, Joost Schymkowitz3,4,*
and Bart De Strooper1,2,*
1Department for Molecular and Developmental Genetics, Flanders
Institute for Biotechnology (VIB), Leuven, Belgium, 2Center for Human
Genetics, KULeuven, Leuven, Belgium, 3Switch Laboratory, Flanders
Institute for Biotechnology (VIB), Brussels, Belgium, 4Vrije Universiteit
Brussel (VUB), Brussels, Belgium, 5IMEC, Bioelectronic Systems Group,
Heverlee, Belgium, 6Laboratory of Medicinal Chemistry, Rega Institute
for Medical Research, Leuven, Belgium, 7Faculty of Science and
Technology, Nanobiophysics, MESAþ Institute for Nanotechnology,
MIRA Institute for Biomedical Technology and Technical Medicine,
University of Twente, Enschede, The Netherlands, 8 Department of
Physics and Astronomy, Laboratory of Solid State Physics and
Magnetism, KULeuven, Belgium and 9Laboratory of Biological
Psychology, KULeuven, Leuven, Belgium
The amyloid peptides Ab40 and Ab42 of Alzheimer’s disease
are thought to contribute differentially to the disease
process. Although Ab42 seems more pathogenic than
Ab40, the reason for this is not well understood. We
show here that small alterations in the Ab42:Ab40 ratio
dramatically affect the biophysical and biological proper-
ties of the Ab mixtures reflected in their aggregation
kinetics, the morphology of the resulting amyloid fibrils
and synaptic function tested in vitro and in vivo. A minor
increase in the Ab42:Ab40 ratio stabilizes toxic oligomeric
species with intermediate conformations. The initial toxic
impact of these Ab species is synaptic in nature, but this
can spread into the cells leading to neuronal cell death.
The fact that the relative ratio of Ab peptides is more
crucial than the absolute amounts of peptides for the
induction of neurotoxic conformations has important
implications for anti-amyloid therapy. Our work also
suggests the dynamic nature of the equilibrium between
toxic and non-toxic intermediates.
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Introduction
Amyloid b (Ab) peptides generated from the amyloid
precursor protein (APP) by b- and g-secretase-mediated clea-
vage (Annaert and De Strooper, 2002) are thought to have
an important function in the neurodegenerative process
in Alzheimer’s disease (AD) (Hardy and Selkoe, 2002).
g-Secretase cleavage of APP generates a heterogeneous mixture
of Ab peptides varying in length at their carboxytermini (Sato
et al, 2003; Qi-Takahara et al, 2005; Kakuda et al, 2006).
Additional heterogeneity is generated at the aminoterminus
by aminopeptidases, glutaminylcyclases and other modifica-
tions (Pike et al, 1995; Saido et al, 1996) (reviewed in De
Strooper, 2010). It has been proposed that some of these
variations might contribute to the neurotoxic properties of
Ab peptides (Schilling et al, 2008).
The major Ab species recovered from serum, cerebrospinal
fluid and cell culture supernatants is 40 amino acids long
(Ab40) (Haass and Selkoe, 1993; Scheuner et al, 1996).
Interest in a second peptide, Ab42, which is detected at
about 10-fold lower levels, was strongly stimulated by the
observation that familial AD causing mutations in the APP
gene and/or in the gene encoding the g-secretase complex
component presenilin increased the relative production of
Ab42 relative to Ab40 (Suzuki et al, 1994; Duff et al, 1996;
Scheuner et al, 1996). We reported earlier (Bentahir et al,
2006) that clinical mutations in presenilin do not necessarily
increase the production of Ab, but that they mainly affect the
spectrum of the Ab peptides generated by g-secretase. As
patients with presenilin mutations present an early and
aggressive form of the disease, it seems then logical to
propose that the absolute quantity of Ab peptides produced
in the brain might be less important than the quality of the Ab
peptides (reflected in a changed Ab42 to Ab40 ratio) for the
generation of elusive toxic Ab species (De Strooper, 2007).
The implications of such hypothesis for current efforts in
drug development is important because lowering the absolute
amounts of Ab in patients would then be less crucial than the
restoration of the correct ratios of Ab peptides. Earlier studies
have already provided evidence that Ab40 and Ab42 affect
each other’s aggregation rates and toxic effects (Snyder et al,
1994; Frost et al, 2003; Yoshiike et al, 2003; Wang et al, 2006;
Kim et al, 2007; Yan and Wang, 2007; Jan et al, 2008).
Generally, it is found that Ab42 has fast aggregation kinetics,
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which can be inhibited by Ab40 in a concentration-dependent
manner. Interesting in vivo studies have further shown that
increased levels of Ab40 peptides in the brain actually might
have a protective effect (Wang et al, 2006; Kim et al, 2007).
In the past, a lot of attention has gone to the accumulation
of Ab in plaques and the relationship between amyloid
plaques and AD. However, little or no correlation was
found between the total burden of Ab peptide deposited
into plaques in the brain and the degree of neurodegeneration
in the patients (Terry et al, 1991; Price and Morris, 1999).
More recently, this discrepancy has been confirmed with
modern amyloid imaging techniques (Aizenstein et al,
2008; Reiman et al, 2009). Obviously, it is possible that
these patients are in a preclinical phase of the disease, and
follow-up studies are underway to investigate this.
Nevertheless, these observations support the concept that
the amyloid fibrils are biologically largely inert and that not
all conformations of Ab are equally toxic (Martins et al, 2008;
Shankar et al, 2008). A series of intermediate soluble aggre-
gates of Ab peptides, such as ‘Ab-derived diffusible ligands’
(ADDLs) (Lambert et al, 1998) or ‘natural toxic oligomers’
(Walsh et al, 2002), have been identified. The mechanism of
their neurotoxic activity remains not only subject of intense
investigation, but also the precise conformation(s) of the
toxic species remains uncertain (Kayed et al, 2003; Hepler
et al, 2006). Dimers were proposed to potently disrupt
synaptic plasticity (Klyubin et al, 2008; Shankar et al,
2008), an Ab species of 56 kDa has been found neurotoxic
in Tg2576 mice (Lesne et al, 2006), lipid-induced oligomers
from mature fibrils (Martins et al, 2008), ADDLs (Lambert
et al, 1998; Gong et al, 2003; Lacor et al, 2007) and annular
assemblies (Lashuel et al, 2002) were shown to exert neuro-
toxic effects, affect synapse function and even memory for-
mation in mice. It should be noted that in many of the
publications, the identified toxic species are presented as
stable, defined structures, although it seems logical to assume
that their assembly and disassembly is a dynamic and con-
tinuous process, at least in the initial stages, and the alter-
native possibility that toxicity is present over a series of
conformers or sizes should not be disregarded (Hepler et al,
2006; Martins et al, 2008; Ono et al, 2009). Toxicity seems to
be higher with tetramers than dimers for instance (Ono et al,
2009). The question is thus how biophysical parameters
influence this process in vivo and affect the relative distribu-
tion of Ab species over toxic and non-toxic conformations
over time. Given the complexity of the biophysical environ-
ment in which Ab aggregation occurs in vivo, such question is
extremely difficult to address. Nevertheless, it is possible to
analyse the dynamic features of this process in simplified and
controlled conditions in vitro, and to evaluate the effect of the
relative concentrations of Ab40 and Ab42 to the generation of
neurotoxic species over time.
We hypothesized here that the early onset of AD by APP
and/or presenilin mutations that increase the Ab42:Ab40
ratios can be explained by interactions between Ab40 and
Ab42, which provide stability to intermediate, neurotoxic
species. We used biophysical methods and a novel cellular
assay to analyse the establishment of neurotoxicity over time
in different Ab mixtures. We found that very minor changes
in the relative amount of Ab42 versus Ab40 (Ab42:Ab40)
has dramatic effects on the dynamic behaviour of toxic
Ab species. Our findings provide an important biological
addition to the original ‘Ab42 seeding hypothesis’ (Jarrett and
Lansbury, 1993), which focused on amyloid fibril formation.
These dynamic oligomeric species exhibit initial synapto-
toxicity and cause later neurotoxicity in primary hippocampal
neurons and affect memory formation in mice, underlining
their potential importance for the understanding of AD.
Results
As the objective of this study was to investigate how Ab40 and
Ab42 affect each others’ biophysical and biological properties,
it was important to prepare a pre-aggregate-free Ab solution
and to validate the mixtures using mass spectrometry
(Supplementary Figure) and anti-Ab40- and anti-Ab42-specific
antibodies (Supplementary Figure 1E). We found that the
sequential treatment of 1,1,1,3,3,3-hexafluor-2-propanol
(HFIP)-Ab films (rPeptide) with HFIP, dimethyl sulphoxide
(DMSO) and then removal of DMSO using a desalting column
provide excellent results with mixtures of primarily mono-
meric peptides in the appropriate relative amounts
(Supplementary Figure 1, see also Materials and methods).
Fourier transform infrared (FTIR) spectroscopy validated the
complete removal of all HFIP and DMSO (not shown).
Aggregation rate of Ab peptides is strongly influenced
by the ratio Ab42:Ab40
Ab peptide was incubated at a concentration of 50mM in
50 mM Tris–HCl, 1 mM EDTA, pH 7.5 at 251C. The aggrega-
tion process of a range of Ab42:Ab40 ratios (10:0 to 0:10)
tested by Thioflavin T (ThT) fluorescence yielded a typical
sigmoidal curve as generally observed for aggregating pro-
teins and peptides (Figure 1A shows four examples) (Harper
and Lansbury, 1997). The formation of an Ab nucleus, which
is not reactive with the fluorescent ThT probe during the
so-called ‘lag phase’, is followed by rapid elongation of
ThT-positive Ab aggregates to form fibrils (the ‘elongation
phase’). Both the length of the lag phase and the rate of
aggregation were affected by the ratio of Ab42:Ab40 (Figure 1B
and C). The lag phase for pure Ab40 alone was B2.5 h
(±0.3 h). Addition of 10% Ab42 (Ab42:Ab40¼1:9) resulted
in a small, but reproducible increase in the lag phase
(B2.9±0.3 h) (Figure 1B). A further increase in the
Ab42:Ab40 ratio decreased paradoxically the length of the
lag phase to B0.5±0.01 h. From a ratio of 3:7 onwards, no
difference was observed compared with Ab42 alone. The
elongation rate was fastest for pure Ab40 and was slowed
down by addition of Ab42 (Figure 1C). Remarkably, judging
from the lag phase of aggregation, the 1:9 and the 3:7 ratio
showed two opposite ends of the spectrum (Figure 1B). These
ratios, in addition to 10:0 and 0:10 were selected for our
further studies. The choice for 3:7 can be also rationalized as
it reflects roughly the ratio of Ab42 and Ab40 in patients with
familial AD (Duff et al, 1996; Mann et al, 1996; Scheuner
et al, 1996; Citron et al, 1997). Thus, both time and the
Ab42:Ab40 ratios are two important parameters when con-
sidering the biophysical properties of Ab, and we decided to
investigate how these parameters determine Ab-oligomer
toxicity. We describe in the rest of the paper the different
Ab mixtures as an Ab42:Ab40 ratio, incubated for an indicated
time at an Ab concentration of 100 mM in 50 mM Tris–HCl,
1 mM EDTA, pH 7.5 at 251C. Thus, (3:7, 2 h) means a ratio of
three Ab42 versus seven Ab40 peptides incubated for 2 h under
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given buffer conditions before addition to the cell culture.
Final concentration of Ab in cell culture is in most experi-
ments 1mM apart from a few in which 10mM was used as
indicated. On the basis of our further experiments, it
appeared that at any time point only a small fraction of the
peptides is in a toxic active conformation.
The Ab42:Ab40 ratio is a driver of acute synaptic
alterations
One problem with Ab toxicity assays is the delay between the
actual preparation of the oligomer samples used for the
biophysical analysis and the moment when the biological
read out becomes available to assess the neurotoxicity. We,
therefore, sought to set up an assay that allows verifying
biological effects of Ab preparations within the time frame of
the biophysical experiments. We plated mouse hippocampal
neurons on microelectrode array (MEA)-based chips
(Figure 2A) (Stett et al, 2003) and recorded spontaneous
firing rates in the neuronal networks before and after treat-
ment with Ab mixtures at a final concentration of 1 mM.
Representative traces of responses of cultures treated with
different Ab mixtures are displayed in Figure 2B.
Interestingly, treatment with pure Ab40 mixtures (0:10, 2 h)
appeared to enhance synaptic activity measured as sponta-
neous firing rate, whereas (1:9, 2 h) mixtures had no effect on
spontaneous synaptic activity (Figure 2B and C). In contrast,
Ab42 alone (10:0, 2 h) or with Ab40 (3:7, 2 h) readily sup-
pressed spontaneous neuronal activity within 40 min after
addition of the peptides (Figure 2B and C). As a control of the
oligomers species status during the course of the recording,
we followed changes in fluorescent ThTemission over 40 min
of Ab mixtures at 1mM in neuronal culture medium at 371C,
which mimics the conditions of the cell culture experiments
(Figure 2D). The Ab mixtures appeared stable over the time
frame of the experiment at least as far as it concerns ThT
incorporation. We next assayed how different Ab42:Ab40
ratios evolve over time with regard to synaptotoxic proper-
ties. Ab42:Ab40 ratio mixtures were incubated for 0, 1.5, 4, 6
and 20 h before addition to the cultures. Synaptic firing rates
were recorded for 40 min as above using MEA. Figure 2E
shows that synaptic effects were little after treatment of the
cells with mixtures of Ab shortly after dissolving them in
buffer (t¼ 0 h, Figure 2E). Toxicity was, however, already
significantly high after 1.5 h of aggregation in the (3:7, 1.5 h)
and the (10:0, 1.5 h) mixtures. The synaptotoxic potential in
the (3:7) and (10:0) ratios remained stable up to 20 h
(Figure 2E). Remarkably, 1:9 or 0:10 ratios did not result in
major synaptic effects at any incubation point (Figure 2E). To
validate the findings, we performed double immunostaining
for the synaptic marker synaptophysin and Ab oligomers
using the A11 antibody (Kayed et al, 2003). Figure 2F
shows that Ab (3:7) and Ab (10:0) mainly co-localized
with the synaptic marker, whereas staining was not observed
with the (1:9) and (0:10) ratio. Extensive washing of
the neurons to remove Ab species did not interfere with
consecutive A11 staining, indicating the rather irreversible
nature of the binding of these synaptic active species to the
neurons (not shown).
To prove Ab specificity of the observed effects, we pre-
incubated cells with anti-oligomer A11 or anti-Ab antibody
6E10 before treatment with Ab (10:0, 2 h) ratio. The altera-
tions in the synaptic activity by toxic intermediates are
indeed Ab specific, as cells pre-incubated with antibodies
are no longer susceptible to the neurotoxic effects
(Figure 2G). We also further explored the reversibility of
these Ab effects on synaptic function. Removal of Ab (3:7,
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Figure 1 Ab42 determines the kinetics of Ab aggregation. (A) Ag-
gregation kinetics of 50 mM Ab ratios in 50 mM Tris, 1 mM EDTA at
251C for 6 h by Thioflavin T (ThT) assay shows how the ratio of
Ab42:Ab40 (e.g. 3:7) influences the aggregation kinetics. The colour
codes are maintained in all following figures. (B) Quantitative
analysis of lag phase, showing the time (hours) of the initial part
of curves as in (A), during which no increase in ThT fluorescence
signal is detected using different Ab42:Ab40 ratios as indicated.
(C) Quantitative analysis of the elongation rate, derived from
(A) as rate of fluorescence change, which is the slope of the linear
phase of exponential growth in (A), using different Ab ratios as
indicated. Numbers are averages of three independent experiments.
Error flags indicate s.d. calculated over the three independent
experiments. Statistical significance of the results was established
by P-values using paired two-tailed t-tests, and only shown for the
four ratios further studied in the text. Statistical significance levels
were in (B, C): *Po0.005, **Po0.001, ***Po0.0001. P-value of
Ab40 (0:10) and (1:9)¼ 0.09, and P-value of Ab40 (0:10) and
(1:9)¼ 0.0058 in panels B and C, respectively.
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2 h) and Ab (10:0, 2 h) after 40 min of incubation on the
neuronal cultures by extensive washes with medium did not
restore synaptic activity over the next 6 h in line with the
immunofluorescence data (Figure 2H). However, 18 h after
the wash out of Ab (3:7, 2 h) and Ab (10:0, 2 h), we found
partial synaptic activity recovery at some electrodes,
although the profile of the action potentials (APs) displayed
a slightly different character than the ones recorded before
the treatment (Figure 2H). Given the long time needed for
some recovery and the fact that the profiles after recovery
were different from those before, it seems likely that this
partial restoration of neuronal activity is due to the genera-
tion of novel synaptic contacts rather than recovery of exist-
ing synapses.
In an alternative paradigm to validate the MEA measure-
ments and to evaluate the effect of Ab on the postsynaptic
response only, we performed patch-clamp experiments on
2-week-old neurons and recorded spontaneous electrical
activity comprising APs and excitatory postsynaptic poten-
tials (EPSPs) (Figure 3). The effects of Ab addition were
already observed after a few minutes (Hartley et al, 1999)
and the changes in APs and EPSPs frequency were, therefore,
assessed at 7 min and compared with the APs and EPSPs
frequency measured during 1 min before Ab was applied
(time point ‘1 min’). It is clear that the Ab (3:7, 2 h) has a
profound effect on the EPSP frequency, indicating a block of
spontaneous postsynaptic depolarizations Neither APs nor
EPSPs were affected by Ab (1:9, 2 h), and significant increase
in APs rate was observed in case of Ab (0:10, 2 h), in line with
the MEA data. As it can be seen, synaptotoxic signatures of
Ab42:40 ratios are similar regardless of extra- or intracellular
mode of measurement.
Toxic Ab species are oligomeric and dynamic structures
We used transmission electron microscopy (TEM) to char-
acterize the morphology of the species populated during fibril
formation. At the starting point of incubation, no fibrils are
detected with any of the different Ab ratios (Figure 4A,
column 0 h). With time, the pure Ab42 (10:0) solution showed
mature fibril formation consistent with the fast nucleation
observed by ThT fluorescence. The fibrils have typical long,
negatively stained amyloid fibril morphology as is frequently
observed for other amyloid-forming proteins or peptides
(Chamberlain et al, 2000). Upon longer incubation, these
fibrils progressively transform into a dense network of clus-
tered fibrils. Ab42:Ab40 (0:10) and (1:9) ratios developed
fibrils after B6 h, which have similar characteristics to the
fibrils observed in the (10:0) ratio, but display in addition a
regular twist pattern, which is not observed in the Ab42 fibrils
(Figure 4A, most right column, arrows indicate twist pattern).
The (3:7) ratio in contrast showed no fibrils at this time point,
and the first aggregates appeared only after B9 h. These
aggregates differed markedly in their morphologies as they
interacted heavily with the uranyl acetate stain used to
visualize the aggregates in TEM and also formed densely
fibrous and fractured networks in which individual fibrils
cannot be distinguished, which is similar to the later stages of
Ab42 aggregation (not shown). Interestingly, the fast nuclea-
tion and aggregation kinetics of the (3:7) ratio as observed
using ThT fluorescence assays (Figure 1) did not coincide
with the early appearance of mature aggregates using elec-
tron microscopy (Figure 4A). This suggested that the (3:7)
ratio rapidly generates small ThT-positive oligomers, but that
these do not propagate towards assemblies that are suffi-
ciently large to allow visualization with EM. Although EM
experiments confirmed clearly the dramatic differences in the
aggregation properties of the different mixtures, they did not
allow visualizing the postulated toxic species responsible for
the synaptic effects observed in the MEA experiments with
the (3:7) ratio. We hence set out to further identify the
presence of smaller oligomeric Ab using the complementary
technique of tapping mode atomic force microscopy (AFM).
The various Ab ratios under investigation were screened at
1.5 h incubation, which is a time point that yields strong
synaptotoxicity for ratios (3:7) and (10:0), but not for ratios
(1:9) and (0:10) (Figure 2E). Interestingly, we observed
oligomer formation for all four ratios of Ab42:Ab40
(Figure 4B), even for the two non-synaptotoxic ratios (1:9)
and (0:10). This finding implies that oligomer formation per
se is not directly linked to the toxic effects of Ab. We infer that
the internal organization of the oligomers might make them
toxic to neuronal cells. Native PAGE showed that (10:0) and
(3:7) already display a wide range of oligomers and fibrillar
material that did not enter the gel after 4 h incubation. SDS–
PAGE in contrast shows at the same time points only low-
molecular weight oligomers (Supplementary Figure S2). It,
therefore, seems that SDS–PAGE dissociates the larger native
structures in the toxic mixtures. The smaller oligomeric SDS-
resistant structures can only be considered ‘building blocks’
of larger toxic structures. As no clear differences were
observed in oligomerization state between the four different
ratios that could explain the variation in cytotoxicity, we used
in situ FTIR spectroscopy to obtain information on the
conformation of the Ab peptides and aggregates in solution.
We found that the initial spectra of the different Ab mixtures
at t¼ 0, when peptides are mainly monomeric, are character-
ized by a broad peak at 1654 cm1 indicative of random coil
structure (Goormaghtigh et al, 1994). This spectrum gradu-
ally converts into a defined and sharper peak at 1627 cm1
(Figure 5). The intensity at 1627 cm1 is indicative for
b-sheet-organized aggregates (Chirgadze and Nevskaya,
1976) and the concomitant increases of the FTIR signal at
1627 cm1 with a decreased signal at 1654 cm1 suggested a
transition from disordered monomeric structures to b-sheet
enriched-oligomeric structures in all mixtures (Figure 5, pa-
nels A–D). Conformational changes are rapidly evolving for
the three Ab ratios that contain Ab42, but the rate of this
change does not seem to predict toxicity: Ab42 is toxic at
1.5 h, whereas ratio 1:9 is not. For Ab40 alone (Figure 5A) and
for Ab (1:9) (Figure 5B), it appears that the loss of unordered
structure (1654 cm1) coincided with a prompt transition into
amyloid fibrillar b-sheet structure (1627 cm1), suggesting a
two-state manner in the mixtures that develop at inverse
rates. This is not observed for Ab (3:7) and Ab (10:0),
suggesting that there is an intermediate, which seems to be
correlated with toxicity.
Long-term cellular toxicity of Ab mixtures
Although the changes in synaptic activity are clearly an
early effect of the toxic conformations in the Ab preparations,
it remained unclear whether these initial hits on the
synapse could also evolve to full cellular neurotoxicity.
This is an important question with regard to AD as the
disease is characterized in essence by neuronal cell loss. We
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investigated, therefore, the effects of the different Ab42:Ab40
ratios over two distinct concentrations (1 mM, which ap-
peared sub-lethal and 10 mM, which appeared lethal) on the
staining pattern of primary hippocampal neurons with
the synaptic marker synaptophysin or with the early apoptotic
markers cleaved caspase-3 and annexinV/propidium iodide
(PI). Treatment of cells with 1mM concentration of Ab ratios
(the same as used for the MEA experiments) for 12h clearly
decreased synaptophysin staining for the Ab (3:7, 2 h) and Ab
(10:0, 2 h) ratios. At this concentration, no or little effect on
appearance of apoptotic markers in the neuronal cells was
observed (Figure 6A; quantified in Figure 6C), further indicat-
ing that the initial effect of the Ab toxic intermediates is at
the synapses. However, 10-fold higher concentration of Ab
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(3:7, 2 h) and Ab (10:0, 2 h) ratios resulted not only in the
loss of synaptophysin staining, but was accompanied by
a strong increase in the early apoptotic markers, annexin
V/PI and cleaved caspase-3 staining (Figure 6B; quantified in
Figure 6D). In contrast, synapses remained intact and no early
apoptotic marker induction was caused by Ab (0:10, 2 h) and
Ab (1:9, 2 h) ratios at both 1 and 10mM concentrations after
12 h of treatment (Figure 6C and D). This finding indicates that
synaptotoxic and cytotoxic effects of Ab intermediates are both
ratio and concentration dependent.
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AP rate for Ab40 (0:10)-treated neurons. The other ratios do not reach statistical significance as compared with control likely because of the
comparatively short time of treatment. (G) Relative change in single excitatory postsynaptic potentials (EPSP). Note the significantly decreased
EPSPs rate for Ab42:Ab40 ratio 3:7 (Po0.03 versus control, unpaired two-tailed t-test) after only 7 min of treatment. Values are per cent of initial
firing rate±s.e.m. of at least three independent experiments. Statistical significance of the data is indicated by *Po0.035 or **Po0.01 in
(F) and (G).
Figure 2 Mixed Ab oligomers result in a rapid synaptotoxic response in primary neurons. (A) Neurons stained with Fluo-4 were cultured
8 days in vitro (DIV) on the MEA chip. (B) Firing pattern of neurons from representative electrodes at 0, 10, 20 and 40 min treatment with
different Ab ratios prepared as indicated (e.g. 0:10, 2 h means an Ab42:Ab40 ratio of 0 versus 10, and 2 h means 2 h incubation before addition
to the culture). Note the significantly decreased firing rate and amplitude for Ab42:Ab40 ratios 10:0 and 3:7 after 20 min of treatment.
(C) Spontaneous electrical synaptic activity recordings of hippocampal neurons during 40 min of treatment with 1mM Ab ratios incubated for
2 h prior to the addition to cells. Values are per cent of initial firing rate±s.e.m. of 3–5 independent experiments. Statistical significance
(unpaired two-tailed t-test) of the data versus control is indicated by *Po0.01 or **Po0.001 in the figure. Notice that a strong reduction in
spontaneous synaptic firing versus correspondent control (buffer-treated chips) can be observed after 20 and 40 min in the medium of the 3:7
and 10:0 Ab42:Ab40 ratios. (D) Oligomers dissolved in culture medium remain stable with regard to ThT tinctorial properties for at least 40 min.
Ab ratios were prepared and at specific time intervals of incubation, that is 0, 1.5, 4 and 22 h, Ab aliquots were removed and diluted to 1mM in
cell culture medium containing ThT. The stability of the aggregates at 371C in cell culture medium was deduced from the stability of the ThT
signal over 40 min. Blue bars represent different Ab42:Ab40 ratios as indicated in the figure. Compare signals directly upon dilution into cell
culture medium (‘0 min’) at 371C with signals obtained after 40 min incubation at 371C (‘40 min’). Values are averages of three experiments.
(E) Different ratios of Ab peptides were generated and added to neuronal cultures diluted to a final concentration of 1 mM, either immediately
(0 h) or after 1.5 h; 4 h, 6 h or 20 h of incubation. Synaptotoxicity was measured by recording a decreased rate of firing 40 min after adding the Ab
mixtures to the neurons. Statistical significance levels determined as a function of s.e.m.: ***Po0.0001, n¼ 6 chips, **Po0.001, n¼ 3 chips,
*Po0.01, n¼ 3 chips, difference between 6 h ratio (3:7) and (10:0): *Po0.012 (unpaired two-tailed t-test). (F) Synaptic localization of mixed
Ab oligomers. Fluorescence microscopy images of hippocampal neurons stained for synaptophysin (red) and Ab oligomers (A11 antibody)
(green) after 1 h treatment with 1 mM of the indicated Ab ratios, incubated for 2 h prior the addition to cells. Right panel: magnification
of selected region stained with synaptophysin (red) and Ab oligomers (A11 antibody, green). Oligomeric Ab co-localizes with synapses.
(G) Rescue of spontaneous electrical synaptic activity after the treatment with ratio (10:0, 2 h) in the presence or absence of anti-oligomer A11
or anti-Ab 6E10 antibody, final concentration 10 mg ml–1. Values are per cent of initial firing rate±s.e.m., of three independent experiments,
except for the control with non-specific antibody, which was performed only once. (H) Example of firing recovery after treatment with 10mM
(10:0, 2 h). Raw data streams are shown in black, and corresponding spike shapes are in red. The treatment completely inhibited spontaneous
activity in 6 min. Then the medium was refreshed, and signals were measured after overnight recovery (18 h). Note partial restoration of initial
firing profile along with appearance of another spike population endowed with slightly different waveform and amplitude. Spike sorting is
performed in MC Rack software.
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We evaluated the time course of caspase-3 activation and
its sub-cellular localization versus the synaptic marker sy-
naptophysin in both sub-lethal (1 mM) and lethal (10mM)
concentrations of the (3:7, 2 h) ratio (Figure 6E). Cells treated
with 1mM (3:7, 2 h) showed that cleaved caspase-3 after 2
and 6 h was mostly observed in areas positive for synapto-
physin staining. Further treatment up to 12 h resulted in loss
of synapses as indicated by loss of staining for synaptophy-
sin; however, the cleaved caspase-3 immunostaining did not
propagate to the soma and nucleus. Treatment with 10 mM
(3:7, 2 h) caused in contrast strong activation of caspase-3 at
the synapses already after 2 h (Figure 6E). In addition,
immunostaining for activated caspase-3 was clearly detect-
able after 6 h in the soma of the cells. At 12 h, this concentra-
tion resulted in loss of synaptic staining with synaptophysin
antibodies and strong staining of activated caspase-3 in the
soma and nucleus indicative of cell apoptosis (Figure 6E). A
similar pattern was detected with (10:0, 2 h), but not for
(0:10, 2 h) or (1:9, 2 h) (not shown). These data indicate that
the Ab toxicity observed at the level of the synapses can
spread towards the cell body depending on the type of Ab
species and concentration of toxic intermediates. In addition,
the observation suggests that synapse toxicity and cellular
toxicity are related.
To further confirm that the different Ab preparations
exerted cellular toxicity, we used a Cell-Titer Blue viability
assay on neurons 48 h after they had been exposed to 10 mM
of different Ab ratios, taken at the start of the aggregation
process (0 h in Figure 6F) and during the propagation reac-
tion (1, 2, 4 and 12 h in Figure 6F). In agreement with the
previous studies, monomers (Figure 6F, 0 h) and mature fibril
preparations (Figure 6, 12 h) are largely inert towards neu-
rons (Aksenov et al, 1996; Martins et al, 2008). In contrast,
the Ab42:Ab40 (3:7, 1 and 2 h) and (10:0, 1 and 2 h) exhibited
clear neurotoxicity (Figure 6F). Both (1:9) and (0:10) did not
exhibit neurotoxicity at any stage of the aggregation process
(Figure 6F). Collectively, these data indicate that stabilized
intermediates in the Ab (10:0) and (3:7) ratios bind to
synapses and inhibit synaptic activity, and affect neuronal
viability at higher concentrations.
1:9
3:7
0 h 4 h 9 h
10:0
0:10
6 hAβ1–42:Aβ1–40 9 h
Ratio 0:10 Ratio 1:9
Ratio 3:7 Ratio 10:0
Buffer
250 nm
20 nm
10 
0 
A
B
Figure 4 Characterization of Ab oligomers with transmission electron microscopy and atomic force microscopy. (A) Transmission electron
microscopy images of Ab ratios incubated for 0, 4, 6 and 9 h. Images shown are representative for two experiments. Time of appearance and
fibril morphology are affected by Ab42:Ab40 ratio and mature fibril formation is delayed for the synaptotoxic 3:7 ratio. The bars represent 0.2 mm
size. The last column shows a magnification of the area indicated by squares in the panels of 9 h. The bars represent 0.04mm size. The arrows
indicate a regular twist pattern observed in the 1:9 and 0:10 fibrils. (B) AFM height images of Ab oligomers formed by incubation of 70mM Ab
for 1.5 h at 251C in 50 mM Tris, 1 mM EDTA. The buffer image is shown as a control. The bar represents 250 nm size.
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Ab ratio affects behaviour and learning alteration
in mice
We finally evaluated to what extent the different Ab ratio
mixtures affected memory formation in mice in vivo. We
injected mice intraventricularly with 6 ml of 100 mM Ab mix-
tures allowed to aggregate for 1.5 h before the injection. The
effect of these Ab preparations on memory formation was
tested using passive avoidance and contextual/auditory-cue
fear conditioning as described previously (Martins et al,
2008). In a light–dark step-through task (passive avoidance
test), animals were trained to memorize an electrical shock
that followed entrance to a dark compartment. When the test
was repeated 24 h later, animals injected with (0:10, 1.5 h) or
(1:9, 1.5 h) recalled the electroshock correctly and showed a
latency to enter the dark room of 232±15 and 273±16 s,
respectively, which was not significantly different from con-
trol mice injected with buffer (256±20 s)-control group not
shown. Injection of (10:0, 1.5 h) or (3:7, 1.5 h) before the
shock, however, inhibited strongly the formation of new
memory. These animals showed significantly faster entrance
latencies of 134±12 and 165±19 s, respectively (Po0.002)
(Figure 7A). Contextual and auditory-cue fear conditioning
experiments confirmed these results. Injection of (10:0)
and (3:7) 90 min before conditioning disturbed the typical
freezing behaviour observed 24 h after the training when
the animals were exposed again to the contextual stimulus
(B50%, Po0.006) or the auditory-cue fear conditioning
experiment (39%, Po0.004) (Figure 7B). These results
show that also in the complex environment of a living animal
clear differences can be observed between the different
Ab ratios similar to those observed in biophysical and
cellular assays.
Discussion
One of the most challenging issues in AD research is the
unresolved nature of the Ab-peptide conformation(s) that
exert neurotoxicity. Our current work shows that Ab-asso-
ciated toxicity is a dynamic property and that a critical
equilibrium between the two major Ab species, Ab40 and
Ab42, exists, which determines the rate of appearance of these
toxic properties as assessed in neuronal cell culture and in
brains of animals in vivo. Our study design has taken this
dynamic behaviour into account by indicating the time of
aggregation of the peptides used in each experiment. We
found that relative high concentrations of Ab are needed to
induce fibrillization and toxic-oligomer conformation.
Although this might seem an artificial situation, one should
realize that by increasing the Ab concentrations, processes
which otherwise take decades become accelerated to the
extent that they can be studied in laboratory conditions.
Most importantly, such high concentrations of Ab might
actually be even quite relevant for what happens in vivo. A
recent publication suggested indeed that intracellular com-
partments accumulate Ab at high mM concentrations, which
could create the conditions for the local formation of the
elusive toxic conformations of Ab peptides (Hu et al, 2009).
It turns out that a small relative increase of Ab42, compar-
able with those observed in patients with familial cases of AD
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Figure 5 Conformational transitions observed using Fourier transform infrared (FTIR) spectroscopy. FTIR spectra were collected continuously
upon incubation of Ab ratios at 251C to investigate conformational changes over time. (A) Ab42:Ab40 (0:10), (B) Ab42:Ab40 (1:9), (C): Ab42:Ab40
(3:7) and (D) Ab42:Ab40 (10:0). Intensity at 1654 cm
1 in red characteristic for disordered structure ( ) and intensity at 1627 cm1 in black (m)
characteristic for amyloid fibril structure. Intensities are averages of three independent experiments and normalized against buffer. Notice that
the transition of ratio (3:7) and (10:0) cannot be explained by a two-state transition model (the two curves do not cross at the 50%
intersection), whereas (0:10) and (1:9) can completely be accounted for by the two states. Insets show typical spectra for the different Ab ratios
recorded at 0 h (black) and after incubation for 8 h (red).
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(Duff et al, 1996; Mann et al, 1996; Scheuner et al, 1996;
Citron et al, 1997), dramatically influenced the final effects
on spontaneous synaptic activity and viability of neuronal
cells and on memory formation in animals. This correlated
with remarkable changes in the biophysical behaviour of the
Ab peptides as assessed in a variety of approaches. Thus, we
find that shifting the ratio of Ab42:Ab40 from (1:9) to (3:7)
shortened nucleation time strongly, whereas fibril elongation
time remained similar as measured by ThT incorporation. In
EM, the (3:7) ratio revealed only visible fibrillar structures
after prolonged incubation compared with the other three
ratios investigated. Both experiments together suggested that
intermediary assemblies of Ab peptides became stabilized in
the (3:7) ratio, which were too small to be observed in EM,
but which, as evaluated in MEA, exerted strong effects on
synaptic activity. In SDS–PAGE, these assemblies apparently
fall apart in small multimeric Ab oligomers as observed by
others (Walsh et al, 2002; Shankar et al, 2008), but from non-
denaturing PAGE analysis, we deduced that these ‘building
blocks’ are part of larger structures present in the toxic
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Figure 6 Mixed Ab oligomers affect synapses at low concentration and induce cell death at higher concentrations. (A, B) Fluorescence
microscopy images of hippocampal neurons stained for annexin V (green)/PI (red) (upper row), cleaved caspase-3 (middle row) and
synaptophysin (green)/DAPI (blue) (bottom row) after 12 h treatment with (A) 1mM Ab ratios and (B) 10 mM Ab ratios incubated for 2 h before
the addition to cells. Fluorescence intensity quantification for annexin V, cleaved caspase-3 and synaptophysin staining (C) 1mM and (D) 10 mM
of Ab ratios. Values are intensity±s.e.m., **Po0.001 and *Po0.003, of five different areas from two independent experiments. (E) Time
course of fluorescence microscopy study of hippocampal neurons stained for synaptophysin (red) and cleaved caspase-3 (green) after treatment
with 1 and 10mM 3:7 ratio Ab oligomers incubated for 2 h prior the addition to cells (blue: DAPI) figure representative for two independent
experiments. (F) Cell-Titer Blue viability assay of hippocampal neurons treated with 10mM Ab ratios incubated for different time periods before
the addition to cells. The Cell-Titer Blue reagent conversion was determined 48 h after the treatment. Values are OD±s.e.m., **Po0.01, three
independent experiments performed in triplicates.
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mixtures on the neuronal cultures. Investigation by AFM
further underlined that oligomeric Ab was present in all Ab
ratio preparations, suggesting that the presence of oligomers
per se are not directly linked with toxic effects. We suggest,
therefore, that the toxic aggregates of Ab in our assays were
dynamic in nature and could assemble and disassemble when
in solution in the culture medium of the cells. In addition,
based on the results obtained by AFM, one can assume that
not the size but the structure of the intermediate oligomers
dictates their stability and synaptotoxic potential. Indeed,
with FTIR spectroscopy, we found indications for particular
conformational transitions in the peptides that are specific for
this postulated toxic intermediate situation. Going from
monomeric Ab (disordered at 1654 cm1) to fibrillar Ab
(parallel b-sheet at 1627 cm1) (Chirgadze and Nevskaya,
1976; Goormaghtigh et al, 1994), we find in the Ab40 (0:10)
or Ab42:Ab40 (1:9) preparations that the unstructured state
converted to the b-sheet conformation without intermediary
structures. In contrast, the patterns of conversion in the
Ab42:Ab40 (3:7) and the Ab42 (10:0) ratios indicated the
existence of an intermediate conformation (Figures 4D and
5C). The current work also suggests the prolonged time
window of existence of such intermediate states in the (3:7)
ratio.
Ab42 drives apparently this reaction. As shown in
Supplementary Figures 3 and 4, interactions of Ab42 and
Ab40 occur random (Supplementary Figures 3 and 4).
Previously, it has been shown that Ab42 induces indeed the
aggregation of Ab40 (Jarrett and Lansbury, 1993; Snyder et al,
1994; Yoshiike et al, 2003; Yan and Wang, 2007; Jan et al,
2008). We show here that the relative amount of Ab42 is most
crucial in this regard as shown by the dramatic shift in
properties from Ab42:Ab40 ratio (1:9) towards the FAD-like
Ab42:Ab40 ratio (3:7). In fact, ratio (1:9) is nucleating very
late (Figure 1), but once the nucleation occurs, this mixture
rapidly forms mature and well-organized fibrils (Figure 4A),
in which oligomer formation is observed by AFM (Figure 4B),
but not by TEM. Collectively, the data suggest that the Ab
(1:9) and (0:10) ratios most probably bypassed the synapto-
toxic stage and aggregated once nucleation had been induced
quite rapidly into non-toxic mature fibrils (Figures 2E–F
and 4A) and, therefore, did not bind and affect synapses.
In contrary, Ab (3:7) and Ab (10:0) ratios were enriched
with synaptotoxic intermediates that bind to synapses and
inhibit spontaneous synaptic activity. It should be mentioned
that it has been already suggested that neurotoxicity by Ab is
not exerted by a specific species, but that in contrast the
polymerization reaction itself, which depends on monomer
concentration and nucleation rate, drives toxicity (Wogulis
et al, 2005). Our data seem indeed more compatible with
a dynamic interpretation of Ab toxicity, and argue against
a simple receptor-ligand mechanism mediated by a precise
Ab species as has been proposed by several others (e.g.
Lauren et al, 2009).
A wide range of evidences indicate that Ab oligomers and
protofibrillar intermediates, regardless of their origin or pre-
paration, attack synapses, block LTP and disrupt cognitive
functions (Walsh et al, 2002; Gong et al, 2003; Cleary et al,
2005; Calabrese et al, 2007; Lacor et al, 2007; Martins et al,
2008; Tew et al, 2008). One of the questions in these assays is
whether the species that exerts the toxicity as measured in the
biological assay is the same as the one that is analysed in the
biophysical assays. We developed, therefore, an acute cellular
assay to measure synaptic effects very early after addition of
the Ab preparations. We observed changes in the sponta-
neous firing rate of neurons in culture already within 20 min
incubation with Ab ratio mixtures (Figure 2D and E). We
confirmed that the ThT tinctorial properties of the different
Ab preparations used were minimally changed over the time
frame of 40 min. This assay was performed in neuronal
culture medium and at the same dilution and temperature
used in the cellular assays, further strengthening our assump-
tion that the toxicity measured in the MEA cellular assay was
indeed associated with the Ab aggregation state characterized
in the biophysical assays. This acute toxicity was further
confirmed by measuring EPSP of neurons in culture: as early
as 7 min after addition of the Ab mixtures toxicity, measured
as decreased rate of EPSP, was detected.
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Figure 7 Toxic Ab affects behaviour and learning of mice.
(A) Passive avoidance; 1.5 h after intraventricular injection with
6 ml of Ab ratios incubated for 2 h before the injection, latency of
entrance in the dark cage during the training (white) was tested.
The latency of entrance during the testing was performed 24 h later
(black) (values are latency mean±s.e.m., Po0.002, control
(n¼ 13), Ab40 and ratio 1:9 (n¼ 12), ratio 3:7 and Ab42 (n¼ 11)).
(B) Conditional fear response; 1 h after intraventricular injection
with 6ml of Ab ratios, habituation was induced. Animals were
exposed to the training after an additional 4 h. The freezing re-
sponse was recorded 24 h later for context-dependent (white bars)
and auditory cue-dependent (black bars) memory formation. Values
are per cent freezing mean±s.e.m., Ab ratios (0:10) and (1:9):
n¼ 13 for ratio (3:7) and (10:0): n¼ 14.
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We addressed the question of synaptotoxic versus cyto-
toxic effects of Ab intermediates. We show that intermediates
from the Ab (3:7) ratio specifically bind synapses (Figure 2F)
without major cytotoxicity as assessed by caspase-3 and
annexin staining (Figure 6). Our data also provide some
preliminary evidence that the initial synaptotoxicity is accom-
panied by some local synaptic activation of caspase-3
(Figure 6) occurring in parallel to the functional inactivation
of synapses (Figure 2), which needs further exploration.
Interestingly, higher concentrations of the Ab(3:7) ratio
caused caspase-3 activation in the soma as well (Figure 6).
The findings in the current manuscript impact on our
understanding of the function of the different Ab species
and their relative contribution to synapse toxicity and neu-
ronal cell death in the brain of AD patients. The paradox of
loss of function of several presenilin mutations causing AD
(reviewed in De Strooper, 2007) indicates that at least in these
FAD cases, a lower generation of Ab peptide can still be
associated with disease and progressive amyloid accumula-
tion. In vivo experiments are in line with this conclusion:
more amyloid pathology was observed in transgenic mice
expressing a PS1 mutant allele over a PS1 null allele than over
a PS1 wild-type allele (Wang et al, 2006). Our work explains
that it is indeed possible to come to very different, patholo-
gically relevant, situations with the same quantitative Ab
load, but with a qualitatively different Ab mix. This could
potentially explain the early and aggressive neurodegenera-
tion in the brain of presenilin FAD patients, even with a loss
of function of g-secretase (Bentahir et al, 2006). If indeed the
specific mix of the different Ab peptides with specific con-
formation in the brain dictates the synapse and neuronal
toxicity potential of the Ab load in FAD and, by extrapolation,
in sporadic AD brain, these observations have obviously
important implications for the development of anti-amyloid
medication.
Materials and methods
Preparation of Alzheimer’s b-peptide ratios
Ab peptide was dissolved at a concentration of 1 mg ml–1 in HFIP
(99þ%, Aldrich Cat. # 10,522-8). Ab42 and Ab40 were then mixed
in molar ratios of (0:10), (1:9), (3:7) and (10:0). HFIP was
evaporated using a gentle stream of argon gas and the peptide film
was resolved using DMSO, (Sigma Cat. # D4540) at a final
concentration of 1 mg ml–1. The peptide was separated from DMSO
with a 5-ml HiTrapTM desalting column (GE Healthcare, Sweden).
Complete removal of DMSO was confirmed by FTIR: DMSO
provides spectral maxima at 1011 and 951 cm1. The peptide was
eluted into a 50-mM Tris, 1 mM EDTA buffer, pH 7.5 and the peptide
concentration was measured using Bradford assay. The samples
were kept on ice until experiments started, with a maximum lag
time of 20 min.
ThT fluorescence
Ab protein concentrations were normalized to 50 mM by further
dilution using 50 mM Tris, 1 mM EDTA containing buffer and a final
concentration of 12mM ThT was added in a Greiner 96-well plate.
The fibrillation kinetics were followed in situ using a Fluostar
OPTIMA fluorescence plate reader at an excitation wavelength of
440 nm and an emission wavelength of 480 nm. Readings were
recorded in triplicate every 10 min for a period of 6 h.
Transmission electron microscopy
Aliquots (5ml) of the Ab preparation were adsorbed to carbon-
coated FormVar film on 400-mesh copper grids (Plano GmbH,
Germany) for 1 min. The grids were blotted, washed twice in
droplets of Milli-Q water and stained with 1% (wt/vol) uranyl
acetate. Samples were studied with a JEOL JEM-2100 microscope
at 200 kV.
Fourier transform infrared spectroscopy
Ab solutions were applied to the FTIR sample holder and incubated
for 8 h at 251C. InfraRed spectra were recorded on a Bruker Tensor
27 infrared spectrophotometer (Bruker Optik GmbH, Ettlingen,
Germany) equipped with a Bio-ATR II accessory. The spectro-
photometer was continuously purged with dried air. Spectra were
recorded at a spectral resolution of 4 cm1 and 120 accumulations
were performed per measurement. FTIR spectra were recorded
every 5 min in situ at a wavelength range from 900 to 3500 cm1.
The obtained spectra were baseline subtracted and rescaled in the
amide I area, which spans from B1600 to B1700 cm1.
Spontaneous synaptic activity recording by MEA
Neurons were plated at 1000 cells mm–2 on an MEA substrate
(Multichannel Systems GmbH, Germany) and grown for 8–10 days.
The spontaneous firing rate of the neuronal network was recorded
simultaneously from at least 10 successful electrodes (out of 60
available) (Pine, 1980; Potter and DeMarse, 2001). During the
recording experiment, a temperature controller from Multichannel
Systems was used to maintain the MEA platform temperature at
371C. The basal firing rate was recorded during 5 min. Upon
treatment with Ab, the spontaneous synaptic activity was con-
tinuously recorded during 40 min. Raw signals from MEA electrodes
were amplified by MEA1060 amplifier (gain 1200) from Multi-
channel Systems and digitized by the A/D MC_Card at a sampling
rate of 25 kHz; MC_Rack 3.5.10 software (Multichannel Systems)
was used for data recording and processing. The raw data stream
was high-pass filtered at 200 Hz, and the threshold for spike
detection was set to 5 s.d. of the average noise amplitude computed
during the first 1000 ms of recording. A number of spikes detected
by every electrode per time bin of 60 s was normalized to baseline
(firing rate in the absence of treatment). After data analysis, the
firing rates at 10, 20 and 40 min of treatment were extracted and
presented as percentage of initial rate.
Patch-clamp experiments
Two-week-old neurons from at least five independent hippocampal
cultures were patch clamped, and spontaneous electrical activity
comprising APs and EPSPs was recorded. Quartz glass pipettes with
an inner diameter of 1 mm were pulled using a P-2000 Laser Puller
(Sutter) to obtain pipettes with series resistance of 2–4 MO. The
pipette solution consisted of 140 mM KCl, 5 mM EGTA, 5 mM NaCl,
5 mM Na2ATP, 10 mM HEPES, 1 mM MgCl2, pH 7.2. After the
formation of a gigaseal, the cell membrane was ruptured using ZAP
pulses to obtain the whole-cell configuration. Then, APs and EPSPs
were recorded in current clamp mode using a Multiclamp 700B
amplifier connected to a Digidata 1440 acquisition card and
Clampex 10.2 software (Molecular Devices). Neurons were kept in
neurobasal cell medium supplemented with 10% HEPES. Different
ratios of Ab were added to the measurement chamber by manual
pipetting. The number of EPSPs before and after the treatment were
analysed in 1 min segments by means of the Clampfit software
(Molecular Devices).
Learning and memory tests
Passive avoidance learning was tested in a step-through box. During
training, dark-adapted mice were placed in the small illuminated
compartment of the box. After 5 s, a sliding door to the larger dark
compartment was opened, and entry latency was recorded. The
door was closed as soon as all four feet were on the grid floor, and a
slight foot shock (0.3 mA, 2 s) was delivered using a constant
current shocker (Med Associates). Retention was tested 24 h later
using the same procedure, and entry was recorded up to 300 s
cutoff. The results are expressed as latency to enter the dark
compartment before and after the foot shock.
In cue- and context-dependent fear conditioning the uncondi-
tioned stimulus (US) (an electric shock) is paired with a CS (the
tone) to elicit a freezing response, a reliable measure of fear in
rodents. On the first day, the animals were placed in the testing
chamber (22.5 32.5 33.3 cm; Plexiglas cage with a grid floor)
and were allowed to acclimatize for 5 min. On day 2, they were first
allowed to explore the testing chamber for 2 min (pre-US score). A
30-s tone (conditioned stimulus (CS)) was delivered (frequency,
2150±200 Hz; Star Micronics, Piscataway, NJ), which coterminated
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with a 2 s, 0.35 mA foot shock (the US). Two minutes later, a second
pairing of the CS and US was presented, followed by another 30 s
exploration (post-US score). Twenty-four hours later, the animals
were returned to the testing chamber for 5 min exploration in the
same context as the previous day (context score). Ninety minutes
later, the animals were returned to the test chamber, but now the
grid floor was hidden with a Plexiglas plate and odourized sawdust
to alter the context of the testing chamber. The animals were
observed for 6 min. During the first 3 min, no stimulus was
delivered (pre-CS score). During the next 3 min phase, the auditory
cue was delivered (CS score). Freezings were automatically
recorded. A freezing score was expressed as the percentage of
freezing, when the threshold was defined equally through all
experiments in each of the five trial blocks.
Statistics
Differences between groups were examined using unpaired two-
tailed t-tests, and one-way or two-way repeated measurements
ANOVA procedures with Fisher’s method. Significance levels for
each experiment are indicated in the figure legends. Significance in
Cell-Titer Blue viability assay, MEA assay, ThT assays
and immunofluorescence intensity assay was established using
two-tailed t-tests.
Additional Materials and methods are in Supplementary data.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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